Skip directly to site content Skip directly to search


Español  Other Languages


Centers for Disease Control and Prevention. CDC twenty four seven. Saving Lives, Protecting People
 Search
		×
			NIOSH
			NIOSH
				All CDC
				Submit
			For a full list of topics:A-Z Index
			Advanced Search
		Advanced Search


NIOSH Radiation Dose Reconstruction Program


Section Navigation
			
			CDC Home








alert icon
            Cybersecurity Modernization Initiative
                We are taking steps to continue to modernize and secure our data, applications, and systems. We completed the first phase and restored many of the functions put on pause in May 2021. Now that the first phase is complete, work will resume at a slower pace but will speed up as new systems and applications are brought online. For more information and updates, please visit our Cybersecurity Modernization Initiative web page.
								

				Nuclear Materials and Equipment Corp. (NUMEC) – Apollo						Print
																Related Pages
										On This Page
			Special Exposure CohortAdvisory Board Work Group on Uranium Refining Atomic Weapons EmployersTechnical DocumentsAdvisory Board and NIOSH DiscussionsPublic CommentsDocument Archive
		
(Site Profile/Docket Number 133)
Location: Apollo, Pennsylvania
Also known as: Babcock & Wilcox Company, NUMEC II, N.M.E. Liquidating Corporation
Special Exposure Cohort Petition Information
The Special Exposure Cohort (SEC) is a unique category of employees established by the Act (42 CFR Part 83). Claims compensated under the SEC do not have to go through the dose reconstruction process. To qualify for compensation under the SEC, a covered employee must meet specific requirements (e.g., must have at least one of 22 “specified cancers,” and have worked for a specified time period at one of the SEC sites). Classes of employees and work sites can be considered for addition to the SEC through a NIOSH petition process. More information about the Special Exposure Cohort can be found on our Frequently Asked Questions page.
Open/Active SEC Petitions
To date, there are no open/active SEC petitions from Nuclear Materials and Equipment Corp. (NUMEC) – Apollo.
Class(es) Added to the SEC
Atomic Weapons Employer (AWE) employees who were monitored or should have been monitored for exposure to ionizing radiation while working at the Nuclear Materials and Equipment Corporation (NUMEC) in Apollo, Pennsylvania from January 1, 1957, through December 31, 1983, for a number of work days aggregating at least 250 work days or in combination with work days within the parameters established for one or more other classes of employees in the Special Exposure Cohort.
Note: This class was established by Petition 80Petitions Qualified for Evaluation
Below is a list of the petitions that qualified for evaluation. Select a petition on the list to view the table for that particular petition.
Petition 47 (Jan 1, 1957 to Dec 31, 1983)
	Petition Information
Steps in Petition Process:
Petition Details:Date Received
December 13, 2005Date Qualified for Evaluation
January 11, 2007Summary of Information in Petition
**Job Titles and/or Job Duties:** All workers
**Period of Employment:** January 1, 1957 through December 31, 1983
**Note:** The information above is what qualified for evaluation. During our evaluation of whether dose reconstructions can adequately be completed for the above job titles and period of employment, information may cause NIOSH to change some the dates or job titles/duties. Therefore, as this petition proceeds through the SEC petition process and if an SEC class is proposed, the proposed class may not exactly match the above information.Copy of the Petition Received
December 13, 2005 [650 KB (9 pages)](January 1, 1957 through December 31, 1983)Federal Register Notice Announcing that a Nuclear Materials and Equipment Corp. (NUMEC) – Apollo SEC Petition has met the Minimum Qualifications for Review and Evaluation
May 18, 2007 [88 KB (1 page)](January 1, 1957 through December 31, 1983)SEC Petition Evaluation Report
Merged with Petition 80Evaluation Report Sent to the Advisory Board
Merged with Petition 80Petition Discussed by the Advisory Board
Merged with Petition 80Advisory Board Recommendation on SEC Petition
Merged with Petition 80HHS Letters to Congress Regarding the SEC Petition
Merged with Petition 80HHS Designation of Additional Members to the SEC
Merged with Petition 80Federal Register Notice: Designation Regarding a Class of Employees for Addition to the Special Exposure Cohort
Merged with Petition 80Effective Date for the SEC Class
Merged with Petition 80Federal Register Notice: Final Effect of Determination of a Class of Employees for Addition to the Special Exposure Cohort
Merged with Petition 80Letter to DOL Regarding the Addition of a New Class of Employees to the SEC
Merged with Petition 80Petition 80 (Jan 1, 1957 to Dec 31, 1983)
	Petition Information
Steps in Petition Process:
Petition Details:Date Received
December 4, 2006Date Qualified for Evaluation
March 28, 2007Summary of Information in Petition
**Job Titles and/or Job Duties:** All office employees who worked at the Apollo site
**Period of Employment:** January 1, 1957 through December 31, 1983
**Note:** The information above is what qualified for evaluation. During our evaluation of whether dose reconstructions can adequately be completed for the above job titles and period of employment, information may cause NIOSH to change some the dates or job titles/duties. Therefore, as this petition proceeds through the SEC petition process and if an SEC class is proposed, the proposed class may not exactly match the above information.Copy of the Petition Received
December 13, 2005 [3.5 MB (91 pages)] (January 1, 1957 through December 31, 1983)
Attachments to the petition:
Supplemental petition form [1.4 MB (13 pages)] January 20, 2006Federal Register Notice Announcing that a Nuclear Materials and Equipment Corp. (NUMEC) – Apollo SEC Petition has met the Minimum Qualifications for Review and Evaluation
February 9, 2007 [44 KB (1 page)] (January 1, 1957 through December 31, 1983)SEC Petition Evaluation Report
September 14, 2007 [389 KB (23 pages)] (January 1, 1957, through December 31, 1983)Evaluation Report Sent to the Advisory Board
September 17, 2007 (January 1, 1957, through December 31, 1983)Petition Discussed by the Advisory Board
The petition was discussed by the Advisory Board on October 3, 2007, during its regular meeting.
**Note:** Agendas and transcripts for Board meetings will be posted on the Advisory Board and Public Meetings page as soon as they become available.Advisory Board Recommendation on SEC Petition
October 26, 2007 [320 KB (2 pages)] (January 1, 1957, through December 31, 1983)HHS Letters to Congress Regarding the SEC Petition
November 29, 2007 [432 KB (10 pages)] (January 1, 1957 through December 31, 1983)HHS Designation/Determination of Additional Members to the SEC
**Designation:**
November 29, 2007 [210 KB (5 pages)] (January 1, 1957 through December 31, 1983)
**Note:** A “designation” means that HHS is recommending a class be added to the SEC. A “determination” means that HHS is recommending a class **not** be added to the SEC.Federal Register Notice: Designation/Determination of a Class of Employees for Addition to the Special Exposure Cohort
**Designation:**
December 13, 2007 [52 KB (2 pages)]
**Note:** A “designation” will be published if there is a recommendation to add a class to the SEC. A “determination” will be published if there is a recommendation **not** to add a class to the SEC.Effective Date for the SEC Class
December 29, 2007 (January 1, 1957 through December 31, 1983)
**Note:** This only applies if the class is added to the SEC.Federal Register Notice: Final Effect of Determination of a Class of Employees for Addition to the Special Exposure Cohort
January 23, 2008 [42 KB (1 page)] (January 1, 1957, through December 31, 1983)
**Note:** This only applies if the class is added to the SEC.Letter to DOL Regarding the Addition of a New Class of Employees to the SEC
January 9, 2008 [21 KB (1 page)] (January 1, 1957, through December 31, 1983)
**Note:** This only applies if the class is added to the SEC.
Advisory Board Work Group on Uranium Refining Atomic Weapons Employers (AWEs)–*formerly TBD 6001 Work Group*
This Work Group reviews technical documents and Special Exposure Cohort (SEC) petitions for uranium refining AWEs assigned to it by the Advisory Board on Radiation and Worker Health. The Work Group makes recommendations to the Board on SEC petitions, reviews reports developed by the Board’s contractor (SC&A), and assists NIOSH and SC&A in resolving issues that arise through the review process.
Sites currently being considered by the Work Group include: General Atomics, Hooker Electrochemical, Reduction Pilot Plant, Westinghouse Electric Corp. (New Jersey), and W.R. Grace (Erwin, TN).
Meeting information (including agendas and transcripts) for this Work Group can be found on either the individual work site pages or on the Advisory Board and Public Meetings page.
*Note: Baker-Perkins Co., Du Pont Deepwater Works, Electro Metallurgical Company,Nuclear Materials and Equipment Corp. (NUMEC) – Apollo, Nuclear Materials and Equipment Corp. (NUMEC) – Parks Township, and United Nuclear Corp. were previously discussed by this Work Group, but are not currently under discussion.*
**Work Group Members:**
Henry A. Anderson, M.D. (Chair)
David Kotelchuck, Ph.D., M.P.H., C.I.H.
David Pompa
**Meeting Information:**
July 19, 2016 Meeting of the Advisory Board’s Uranium Refining Atomic Weapons Employers (AWEs) Work Group
Time/Location:
9:00 a.m. (Eastern Time) Meeting Type: Face-to-Face; Public, No Comment Period
Cincinnati Airport Marriott 2395 Progress Dr. Hebron, KY 41048 Phone: 859-586-0166 Toll-Free: 1-877-222-7570 Fax: 859-586-0266
Teleconference: +1-866-659-0537 Participant Code: 9933701
Available Meeting Items:
Agenda [75 KB (2 pages)]
Transcript [664 KB (207 pages)]Discussion/Background Papers:
SC&A Draft: Review of Special Exposure Cohort Evaluation Report for Westinghouse Electric Corp. SEC-00217, Rev. 0 [401 KB (20 pages)] July 30, 2015
SC&A Draft: SC&A Review of DCAS-TKBS-0009, Rev. 2 for Hooker Electrochemical Company [159 KB (11 pages)] June 28, 2016
NIOSH White Paper: NUMEC Issues and Feasibility of Coworker Model, Rev. 0 [748 KB (19 pages)] June 23, 2016
SC&A Memo: SC&A’s Review of NIOSH’s White Paper Addressing Issues on the Coworker Model for United Nuclear Corporation [79 KB (3 pages)] June 3, 2016
NIOSH/DCAS Memo: Response to SC&A’s Comments on SEC Evaluation Report for Westinghouse Electric Corp.SEC-00217 [225 KB (2 pages) May 24, 2016
SC&A Draft: SC&A Assessment of Selected NIOSH Responses to SC&A NUMEC Site Profile Findings [352 KB (14 pages)] August 14, 2015
SC&A Draft: Review of Special Exposure Cohort Evaluation Report for Westinghouse Electric Corp. SEC-00217, Rev. 0 [401 KB (20 pages)] July 30, 2015
August 3, 2015 Teleconference Meeting of the Advisory Board’s Work Group on Uranium Refining Atomic Weapons Employers (AWEs)
Time/Location:
10:00 a.m. (Eastern Time)
Meeting Type: Teleconference; Public, No Comment Period
Teleconference: +1-866-659-0537 Participant Code: 9933701
Available Meeting Items:
Agenda [15 KB (1 page)]
Transcript [878 KB (179 pages)]Discussion/Background Papers:
NIOSH/DCAS: NIOSH Responses to SC&A Review of ORAUT-TKBS-0041, Rev. 02: Site Profile for Nuclear Materials and Equipment Corporation, Apollo and Parks Township, Pennsylvania Response Paper, Rev. 0-A [859 KB (19 pages)] May 14, 2015
SC&A Draft: Review of the NIOSH Site Profile for Nuclear Materials and Equipment Parks Township and Apollo Sites [834 KB (74 pages)] Contract No. 200-2009-28555 SCA-TR-SP2013-0038 April 19, 2013
SC&A Draft: Issues Resolution Matrix for W.R. Grace & Company in Erwin, Tennessee Site Profile, Rev. 0 [98 KB (8 pages)] January 16, 2013
SC&A Draft: Review of the NIOSH Site Profile for the W.R. Grace and Company in Erwin, Tennessee [275 KB (39 pages)] Contract No. 200-2009-28555 SCA-TR-SP2013-0041 January 16, 2013Technical Documents
If the energy employee’s personal radiation information is incomplete, NIOSH will use other sources to estimate the radiation dose. This may involve using technical documents called Site Profiles, Technical Basis Documents, and Technical Information Bulletins.
Site Profile
Site Profile for Nuclear Materials and Equipment Corporation, Apollo and Parks Township, Pennsylvania, Rev. 4 [5 MB (111 pages)] Revised March 13, 2017
**Revision Includes:** Adds Section 5.1.3 for evaluation of internal dose from 238Pu when bioassay data are available based on DCAS-RPT-0005, Alternative Dissolution Models for Insoluble Pu-238. Updated guidance in Section 5.2.5 for evaluation of recycle uranium contaminants referencing current revision of the Feed Materials Production Center – Occupational Internal Dose, Rev 02. Incorporates formal ORAUT and NIOSH review comments. Table 6-2 and Sections 6.3.1 and 6.3.2 were updated in response to SC&A Finding 12 regarding dosimetry inconsistencies.Advisory Board and NIOSH Comments and Discussion Papers on Nuclear Materials and Equipment Corp. (NUMEC) – Apollo
The Nuclear Materials and Equipment Corp. (NUMEC) – Apollo discussion papers listed below are working documents prepared by NIOSH or its contractor for use in discussions with the Advisory Board on Radiation and Worker Health or its Working Groups or Subcommittees. Draft, preliminary, interim, and white paper documents are not final NIOSH or Advisory Board (or their technical support and review contractors) positions unless specifically marked as such. These documents represent preliminary positions taken on technical issues prepared by NIOSH or its contractor.
The discussion papers have been reviewed to identify and redact any information that is protected by the Privacy Act 5 USC §552a and have been cleared for distribution.
SC&A Draft: SC&A’s Evaluation of ORAUT-OTIB-0049, Revision 02, “Estimating Doses for Plutonium Strongly Retained in the Lung” [1.3 MB (39 pages)]
            Contract No. 75D30119C04183
            Document No. SCA-TR-2021-PR049, Revision 0
            October 7, 2021
SC&A Draft: Review of Revision 03 to the Site Profile for Nuclear Materials and Equipment Corporation, Apollo and Parks Township, Pennsylvania [272 KB (35 pages)] February 6, 2017
NIOSH White Paper: NUMEC Issues and Feasibility of Coworker Model, Rev. 0 [748 KB (19 pages)] June 23, 2016
SC&A Draft: SC&A Assessment of Selected NIOSH Responses to SC&A NUMEC Site Profile Findings [352 KB (14 pages)] August 14, 2015
NIOSH/DCAS: NIOSH Responses to SC&A Review of ORAUT-TKBS-0041, Rev. 02: Site Profile for Nuclear Materials and Equipment Corporation, Apollo and Parks Township, Pennsylvania Response Paper, Rev. 0-A [859 KB (19 pages)] May 14, 2015
SC&A Draft: Review of the NIOSH Site Profile for Nuclear Materials and Equipment Parks Township and Apollo Sites [834 KB (74 pages)] April 19, 2013
Public Comments on Nuclear Materials and Equipment Corp. (NUMEC) – Apollo Documents
How to Submit Comments
Comments on Nuclear Materials and Equipment Corp. (NUMEC) – Apollo Documents can be submitted to the NIOSH Docket Officer electronically by email at nioshdocket@cdc.gov or printed comments can be mailed to:
NIOSH Docket Office Robert A. Taft Laboratories, MS-C34 1090 Tusculum Avenue Cincinnati, OH 45226 Please include the Site Profile/Docket Number (133) on all comments.
Comments Received
At this time, no comments have been submitted on Nuclear Materials and Equipment Corp. (NUMEC) – Apollo documents.
Document Archive for Nuclear Materials and Equipment Corp. (NUMEC) – Apollo
Site Profile for Nuclear Materials and Equipment Corporation, Apollo and Parks Township, Pennsylvania
Revised August 25, 2016 [5.5 MB (109 pages)]
**Revision Includes:** Response to the S. Cohen & Associates review. Updated Table 2-3 to revise operating periods for Parks Township activities. Revised Section 5.1 and Table 5-3 to provide additional information on plutonium mixtures and evaluation of internal dose from plutonium mixtures and associated radionuclides. Added Section 5.2.2.4 to provide guidance on evaluation of intakes based on uranium fluorimetric bioassays. Updated Table 5-8 to include a few more MDA values for lung counts of 239Pu and 241Am. Guidance was added to use the maximum MDA values for years when the bioassay records do not provide an MDA value. Revised Section 5.2.4 to eliminate use of ORAUT-OTIB-0054 for evaluation of intake of associated fission and activation products. Only the doses from listed radionuclides are to be evaluated. Revised Section 5.2.5 to indicate recycled uranium contaminants should be included in the evaluation of the material solubility type that gives the highest internal dose. Added Section 6.5.2.4 and Tables 6-8 and 6-9 to provide guidance on estimation of neutron dose before 1969 using neutron-to-photon ratios. Revised Table 7-1 to include whole-body dose and skin dose with guidance to apply the isotropic exposure dose conversion factors. This is consistent with the evaluations performed for chronic lymphocytic leukemia. Included exposure to thorium in the table. Added Table 7-2 to provide guidance on assignment of onsite external dose for organs affected by shallow dose. Revised Table 7-3 to use general air sampling data rather than breathing zone data as the basis for intakes of residual uranium. Added Table 7-4 for residual thorium intakes on the same basis. Revised the air concentration for residual air concentrations at Apollo and Parks Township uranium facilities to be based on a resuspension factor of 1×10-5 (rather than 1 × 10-6) and updated Tables 7-3, 7-4, and 7-7. Added Attachment B to provide guidance on evaluation of the various dosimetry reports available in the dosimetry records for NUMEC workers. Incorporates formal internal and NIOSH review comments. Constitutes a total rewrite of the document.
Revised November 26, 2012 [1.26 MB (89 pages)]
**Revision Includes:** Change in guidance of dose during residual period and change in guidance on assignment of medical X-ray dose. Sections 3.0, 7.4.1, 7.4.2 were revised. Table 7-1 was deleted and Tables 7-2 (now 7-1), 7-3 (now 7-2) and 7-4 (now 7-3) were revised. A glossary was added. Incorporates formal internal and NIOSH review comments. Constitutes a total rewrite of the document.
Revised February 26, 2010 [2 MB (89 pages)]
**Revision Includes:** Revises minimum detectable concentration for plutonium in urine value based on updated analysis of bioassay data. This resulted in changes to Section 5.2 on pages 44 and 45 and Table 5-4 on page 45. Updated references on pages 43,44, 51, 82-83. Added reference on page 81 and updated other references on pages 82-83 in the Reference Section. No changes occurred as a result of formal internal review. Incorporates formal NIOSH review comments.
Revised June 2, 2009 [1.5 MB (89 pages)]
**Revision Includes:** Incorporates the Parks Township facility. Incorporates formal internal and NIOSH review comments. Constitutes a total rewrite of the document.
Approved September 26, 2008 [1.2 MB (67 pages)]
**Revision Includes:** New Technical Basis Document for Nuclear Materials and Equipment Corporation (NUMEC) in Apollo, Pennsylvania. Incorporates formal internal and NIOSH review comments.
							
					
							Last Reviewed:  June 30, 2022						Source: 	National Institute for Occupational Safety and Health
					Facebook
        Twitter
        LinkedIn
        Syndicate homeRadiation Dose ReconstructionAbout DCASThe Act/EEOICPADose Reconstruction (DR)plus iconDataplus iconSourcesFormats & TypesSensitive DataWork History                            Phone CallData Search and Capture EffortsMethodsProductionTechnical Documents Used in Dose ReconstructionsProgram Evaluation Reports and PlansQuality Assurance and Quality ControlSupport ContractorSoftware (IMBA)RECA ClaimsProbability of Causationplus iconCalculating PCNews & UpdatesNIOSH-IREP SoftwareSpecial Exposure Cohortplus iconSubmit a PetitionCheck Petition Statusplus iconSEC Status TableGet HelpResidual ContaminationAdvisory Boardplus iconPublic MeetingsSubcommittee and Work GroupsSEC Petition RecommendationsTechnical Support for the Review of NIOSH Dose Reconstruction ProgramReports from the Advisory Board's Technical Support ContractorTechnical Review Summaries from the Technical Support ContractorProceduresCorrespondenceWork Site InformationPublications & ProductsProgram ReviewsReports to CongressPolicies, Procedures, and GuidelinesNIOSH Public DocketRelated Program LinksContact UsHELPplus iconHelp A – ZAccessibilityAcronymsFrequently Asked Questions (FAQs)plus iconThe ActCase ConcernsClaimant CorrespondenceConflict or BiasDose ReconstructionFreedom of Information Act (FOIA)National Defense Authorization ActNIOSH-IREPProbability of CausationResidual Contamination ReportResponsibilities under Subtitle B of EEOICPA (The Act)Special Exposure CohortTechnical DocumentsWork History Phone CallGlossary Follow NIOSH Facebook
Pinterest
Twitter
YouTube
 NIOSH Homepage NIOSH A-Z
Workplace Safety & Health Topics
Publications and Products
Programs
Contact NIOSH


About CDC
					Contact Us
					800-232-4636
 Facebook Twitter Instagram LinkedIn Youtube Pinterest Snapchat
 CONTACT CDC
				Contact Us
							Call 800-232-4636
							Email Us
			ABOUT CDC
				About CDC
							Jobs
							Funding
			POLICIES
				Accessibility
							External Links
							Privacy
							Policies
							No Fear Act
							FOIA
							OIG
							Nondiscrimination
							Vulnerability Disclosure Policy
			CONNECT WITH US
				Facebook
								Twitter
								Instagram
								LinkedIn
							Youtube
								Pinterest
								Snapchat
								Email
			LANGUAGES
				Español
							繁體中文
							Tiếng Việt
							한국어
							Tagalog
							Русский
							العربية
							Kreyòl Ayisyen
							Français
							Polski
							Português
							Italiano
							Deutsch
							日本語
							فارسی
							English


U.S. Department of Health & Human Services
			Accessibility
			External Links
			Privacy
			Policies
			No Fear Act
			FOIA
			Nondiscrimination
			OIG
			Vulnerability Disclosure Policy
			USA.gov


Exit Notification / Disclaimer Policy Close
 Links with this icon  indicate that you are leaving the CDC website. The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website.
				Linking to a non-federal website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website.
				You will be subject to the destination website's privacy policy when you follow the link.
				CDC is not responsible for Section 508 compliance (accessibility) on other federal or private website. Website Disclaimers
 Cancel Continue